Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 1
1973 1
1975 1
1976 1
1986 2
1987 1
1988 3
1989 3
1990 2
1991 6
1992 5
1993 5
1994 12
1995 5
1996 9
1997 6
1998 7
1999 8
2000 5
2001 6
2002 7
2003 9
2004 7
2005 4
2006 6
2007 6
2008 7
2009 9
2010 8
2011 10
2012 5
2013 5
2014 6
2015 7
2016 4
2017 11
2018 7
2019 6
2020 10
2021 17
2022 8
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Essential thrombocythemia and pregnancy.
Valera MC, Parant O, Vayssiere C, Arnal JF, Payrastre B. Valera MC, et al. Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):141-7. doi: 10.1016/j.ejogrb.2011.04.040. Epub 2011 Jun 2. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21640467 Review.
Essential thrombocythaemia (ET) is an acquired myeloproliferative neoplasm, characterised by persistent thrombocytosis and a tendency for either thrombosis or haemorrhage. ...Maternal complications are relatively rare and essentially represented by thromboembolic an …
Essential thrombocythaemia (ET) is an acquired myeloproliferative neoplasm, characterised by persistent thrombocytosis and a t …
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A, Vannucchi AM, Barbui T. Tefferi A, et al. Am J Hematol. 2024 Apr;99(4):697-718. doi: 10.1002/ajh.27216. Epub 2024 Jan 25. Am J Hematol. 2024. PMID: 38269572 Review.
OVERVIEW: Essential thrombocythemia is a Janus kinase 2 (JAK2) mutation-prevalent myeloproliferative neoplasm characterized by clonal thrombocytosis; clinical course is often indolent but might be interrupted by thrombotic or hemorrhagic complications, microcirculat …
OVERVIEW: Essential thrombocythemia is a Janus kinase 2 (JAK2) mutation-prevalent myeloproliferative neoplasm characterized by …
Essential thrombocythemia and pregnancy.
Griesshammer M, Heimpel H, Pearson TC. Griesshammer M, et al. Leuk Lymphoma. 1996 Sep;22 Suppl 1:57-63. doi: 10.3109/10428199609074361. Leuk Lymphoma. 1996. PMID: 8951773 Review.
A review of the literature disclosed 106 pregnancies (preg.) in 57 women with essential thrombocythemia (ET). ...However, no definitive answer can be given on the ideal management for women with ET during pregnancy. A European register should be set up …
A review of the literature disclosed 106 pregnancies (preg.) in 57 women with essential thrombocythemia (ET). ...Howeve …
Essential thrombocythemia during pregnancy.
Eliyahu S, Shalev E. Eliyahu S, et al. Obstet Gynecol Surv. 1997 Apr;52(4):243-7. doi: 10.1097/00006254-199704000-00021. Obstet Gynecol Surv. 1997. PMID: 9095490 Review.
Essential thrombocythemia is a myeloproliferative disorder characterized by a persistent increase in the platelet count. ...This article describes pregnancy outcomes and reviews the suggested treatments....
Essential thrombocythemia is a myeloproliferative disorder characterized by a persistent increase in the platelet count. ...Th …
Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Tefferi A, Barbui T. Tefferi A, et al. Am J Hematol. 2023 Sep;98(9):1465-1487. doi: 10.1002/ajh.27002. Epub 2023 Jun 26. Am J Hematol. 2023. PMID: 37357958 Review.
The current review also includes specific treatment strategies in the context of pregnancy, splanchnic vein thrombosis, pruritus, perioperative care, and post-PV MF....
The current review also includes specific treatment strategies in the context of pregnancy, splanchnic vein thrombosis, pruritus, per …
What factors determine the pregnancy outcome in patients with essential thrombocythemia?
Kwiatkowski J, Kuliszkiewicz-Janus M, Potoczek S, Jaźwiec B, Wróbel T, Małecki R. Kwiatkowski J, et al. J Matern Fetal Neonatal Med. 2022 Dec;35(24):4734-4738. doi: 10.1080/14767058.2020.1863362. Epub 2021 Apr 1. J Matern Fetal Neonatal Med. 2022. PMID: 33792458
Objectives: Treatment of essential thrombocythemia (ET) is particularly challenging in pregnancy due to the increased risk of thromboembolic complications. ...The influence of anticoagulant, antiplatelet and cytoreductive therapy on the course and outcome of …
Objectives: Treatment of essential thrombocythemia (ET) is particularly challenging in pregnancy due to the increased r …
Essential thrombocythemia.
Harrison CN, Green AR. Harrison CN, et al. Hematol Oncol Clin North Am. 2003 Oct;17(5):1175-90, vii. doi: 10.1016/s0889-8588(03)00082-0. Hematol Oncol Clin North Am. 2003. PMID: 14560781 Review.
Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders. There is as yet no pathognomonic diagnostic test, and patients who currently fall into the category of essential thrombocythemia are likely to …
Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders. There is as yet n …
Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Gangat N, Tefferi A. Gangat N, et al. Am J Hematol. 2021 Mar 1;96(3):354-366. doi: 10.1002/ajh.26067. Epub 2020 Dec 28. Am J Hematol. 2021. PMID: 33296529 Free article. Review.
Pregnancy in the context of myeloproliferative neoplasms (MPN) poses unique fetal and maternal challenges. Current literature in this regard mostly involves essential thrombocythemia (ET) and less so polycythemia vera (PV) or myelofibrosis. ...
Pregnancy in the context of myeloproliferative neoplasms (MPN) poses unique fetal and maternal challenges. Current literature in this …
Essential thrombocythemia.
Finazzi G, Harrison C. Finazzi G, et al. Semin Hematol. 2005 Oct;42(4):230-8. doi: 10.1053/j.seminhematol.2005.05.022. Semin Hematol. 2005. PMID: 16210036 Review.
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philadelphia (Ph) chromosome-negative myeloproliferative disorders (MPDs) has recently been achieved. ...
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philad …
Essential thrombocythemia.
Schafer AI. Schafer AI. Prog Hemost Thromb. 1991;10:69-96. Prog Hemost Thromb. 1991. PMID: 2008534 Review. No abstract available.
241 results